Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial by Auob Rustamzadeh, Nader Sadigh, Zahra Vahabi, Fatemeh Khamseh, Nafiseh Mohebi, Zahra Ghobadi, Fatemeh Moradi

Get full text